| Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade M Schmittnaegel, N Rigamonti, E Kadioglu, A Cassará, C Wyser Rmili, ... Science translational medicine 9 (385), eaak9670, 2017 | 481 | 2017 |
| Role of angiopoietin-2 in adaptive tumor resistance to VEGF signaling blockade N Rigamonti, E Kadioglu, I Keklikoglou, CW Rmili, CC Leow, M De Palma Cell reports 8 (3), 696-706, 2014 | 228 | 2014 |
| The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2Hi Macrophages in Breast Cancer and Pancreatic Neuroendocrine Tumors AS Harney, GS Karagiannis, J Pignatelli, BD Smith, E Kadioglu, SC Wise, ... Molecular cancer therapeutics 16 (11), 2486-2501, 2017 | 128 | 2017 |
| The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2Hi Macrophages in Breast Cancer and Pancreatic Neuroendocrine Tumors AS Harney, GS Karagiannis, J Pignatelli, BD Smith, E Kadioglu, SC Wise, ... Molecular cancer therapeutics 16 (11), 2486-2501, 2017 | 128 | 2017 |
| Overcoming microenvironmental resistance to PD-1 blockade in genetically engineered lung cancer models A Martinez-Usatorre, E Kadioglu, G Boivin, C Cianciaruso, A Guichard, ... Science translational medicine 13 (606), eabd1616, 2021 | 51 | 2021 |
| Periostin limits tumor response to VEGFA inhibition I Keklikoglou, E Kadioglu, S Bissinger, B Langlois, A Bellotti, G Orend, ... Cell reports 22 (10), 2530-2540, 2018 | 41 | 2018 |
| Proteomic analysis of low-grade, early-stage endometrial carcinoma reveals new dysregulated pathways associated with cell death and cell signaling Á López-Janeiro, I Ruz-Caracuel, JL Ramón-Patino, V De Los Ríos, ... Cancers 13 (4), 794, 2021 | 31 | 2021 |
| Dual angiopoietin-2/VEGFA inhibition elicits anti-tumor immunity that is enhanced by PD1 blockade M Schmittnaegel, N Rigamonti, E Kadioglu, A Cassara, CW Rmili, ... Journal Of Vascular Research 54, 4-4, 2017 | 24 | 2017 |
| Cancer metastasis: perivascular macrophages under watch E Kadioglu, M De Palma Cancer Discovery 5 (9), 906-908, 2015 | 19 | 2015 |
| The association between the tumor immune microenvironments and clinical outcome in low‐grade, early‐stage endometrial cancer patients Á López‐Janeiro, M Villalba‐Esparza, ME Brizzi, D Jiménez‐Sánchez, ... The Journal of Pathology 258 (4), 426-436, 2022 | 7 | 2022 |
| Role of angiopoietin-2 in adaptive tumor resistance to VEGF signaling blockade. Cell Rep. 2014; 8: 696–706 N Rigamonti, E Kadioglu, I Keklikoglou, C Wyser Rmili, CC Leow, ... Back to cited text, 0 | 5 | |
| Weakly supervised deep learning to predict recurrence in low-grade endometrial cancer from multiplexed immunofluorescence images D Jiménez-Sánchez, Á López-Janeiro, M Villalba-Esparza, M Ariz, ... NPJ Digital Medicine 6 (1), 48, 2023 | 3 | 2023 |
| Determinants of tumor resistance to anti-angiogenic immunotherapy in mouse models of Kras-mutant NSCLC A Martinez-Usatorre, E Kadioglu, C Cianciaruso, A Guichard, B Torchia, ... Cancer Research 81 (13_Supplement), 75-75, 2021 | | 2021 |
| O4 Mechanisms of lung cancer hyper-progression promoted by PD-1 immune checkpoint blockade A Martinez-Usatorre, E Kadioglu, C Cianciaruso, B Torchia, J Faget, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 2), A5-A5, 2020 | | 2020 |
| Anti-angiogenic immunotherapy for lung cancer E Kadioglu EPFL, 2019 | | 2019 |
| Group ID U12442 Affiliated authors Andany, Soledad CM Baer, T Beltraminelli, TS Berg, D Biziato, G Boivin, C Cianciaruso, ... | | |
